IPC Issues Drug Safety Alert Linking Clonidine to Hyponatremia Risk
The Indian Pharmacopoeia Commission (IPC), acting through the National Coordination Centre of the Pharmacovigilance Programme of India (NCC-PvPI), has officially issued a critical drug...
AstraZeneca’s Ultomiris®️ Cuts Proteinuria by 43.4% in Phase – 3 Trial
Alexion, AstraZeneca Rare Disease, announced positive results from a prespecified interim analysis of the global Phase III I CAN trial. The data demonstrate...
Drug Control Raid in Howrah: Large Stock of Medicines Seized, Samples Sent for Testing
A multi-day operation by the Drug Control Department in Howrah has led to the seizure of a large quantity of medicines from a godown...
Telangana & South Africa Forge Strategic Alliance in Pharma, Medical Tourism, and ‘Bharat Future City
Telangana Chief Minister A Revanth Reddy hosted a high-level bilateral meeting with a South African delegation led by Deputy President Paul Mashatile to expand...
24 Nations, One Standard — India’s Pharmacopoeia Goes Global
The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with Lao PDR's Food and Drug Department and Ministry of Health, marking a...
CDSCO Advises Pharma Companies to Track and Report Drug Side Effects
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued a firm directive to all medicine manufacturers to build and maintain proper...
